Page last updated: 2024-09-04

platycodin d and Angiogenesis, Pathologic

platycodin d has been researched along with Angiogenesis, Pathologic in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
An, SE; Chung, WY; Jung, MJ; Kim, KR; Lee, SK; Park, J; Park, KK; Son, JA; Son, SH; Yang, HJ1
Chen, HZ; Fang, C; Gao, YG; Guan, YY; Liu, HJ; Liu, YR; Lu, Q; Luan, X; Xu, JR; Zhao, M1
Khan, M; Ma, T; Maryam, A; Mehmood, T; Zhang, H1

Reviews

1 review(s) available for platycodin d and Angiogenesis, Pathologic

ArticleYear
Killing cancer with platycodin D through multiple mechanisms.
    Journal of cellular and molecular medicine, 2016, Volume: 20, Issue:3

    Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Survival; Cell Transformation, Neoplastic; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Neoplasm Invasiveness; Neoplasms; Neovascularization, Pathologic; Saponins; Triterpenes

2016

Other Studies

2 other study(ies) available for platycodin d and Angiogenesis, Pathologic

ArticleYear
Platycodin D Inhibits Vascular Endothelial Growth Factor-Induced Angiogenesis by Blocking the Activation of Mitogen-Activated Protein Kinases and the Production of Interleukin-8.
    The American journal of Chinese medicine, 2022, Volume: 50, Issue:6

    Topics: Angiogenesis Inhibitors; Animals; Cell Movement; Extracellular Signal-Regulated MAP Kinases; Human Umbilical Vein Endothelial Cells; Humans; Interleukin-8; Mice; Neovascularization, Pathologic; Saponins; Triterpenes; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

2022
Platycodin D inhibits tumor growth by antiangiogenic activity via blocking VEGFR2-mediated signaling pathway.
    Toxicology and applied pharmacology, 2014, 11-15, Volume: 281, Issue:1

    Topics: Angiogenesis Inhibitors; Animals; Campanulaceae; Cell Line, Tumor; Cell Survival; Chick Embryo; Chorioallantoic Membrane; Dose-Response Relationship, Drug; Human Umbilical Vein Endothelial Cells; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Saponins; Signal Transduction; Triterpenes; Tumor Burden; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays

2014